Gene · 23186
Papers2,104
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,104
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High-Throughput Screening and Proteomic Characterization of Compounds Targeting Myeloid-Derived Suppressor Cells. | Mol Cell Proteomics | 2023 | 37586548 | PubTator, text mining | PubMed |
| PI3K/AKT signaling pathway as a critical regulator of epithelial-mesenchymal transition in colorectal tumor cells. | Cell Commun Signal | 2023 | 37580737 | PubTator, text mining | PubMed |
| HDAC1/2/3 are major histone desuccinylases critical for promoter desuccinylation. | Cell Discov | 2023 | 37580347 | PubTator, text mining | PubMed |
| HDAC3 and HDAC8 PROTAC dual degrader reveals roles of histone acetylation in gene regulation. | Cell Chem Biol | 2023 | 37572669 | PubTator, text mining | PubMed |
| Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex. | J Biol Chem | 2023 | 37536630 | PubTator, text mining | PubMed |
| LSD1: an emerging face in altering the tumor microenvironment and enhancing immune checkpoint therapy. | J Biomed Sci | 2023 | 37525190 | PubTator, text mining | PubMed |
| Application of Ligand- and Structure-Based Prediction Models for the Design of Alkylhydrazide-Based HDAC3 Inhibitors as Novel Anti-Cancer Compounds. | Pharmaceuticals (Basel) | 2023 | 37513880 | PubTator, text mining | PubMed |
| LSD1-Based Reversible Inhibitors Virtual Screening and Binding Mechanism Computational Study. | Molecules | 2023 | 37513188 | PubTator, text mining | PubMed |
| Super-enhancers complexes zoom in transcription in cancer. | J Exp Clin Cancer Res | 2023 | 37501079 | PubTator, text mining | PubMed |
| Collateral lethality between HDAC1 and HDAC2 exploits cancer-specific NuRD complex vulnerabilities. | Nat Struct Mol Biol | 2023 | 37488358 | PubTator, text mining | PubMed |
| Targeting LSD1 in tumor immunotherapy: rationale, challenges and potential. | Front Immunol | 2023 | 37483603 | PubTator, text mining | PubMed |
| TRPS1 modulates chromatin accessibility to regulate estrogen receptor (ER) binding and ER target gene expression in luminal breast cancer cells. | bioRxiv | 2023 | 37461612 | PubTator, text mining | PubMed |
| The Talented LncRNAs: Meshing into Transcriptional Regulatory Networks in Cancer. | Cancers (Basel) | 2023 | 37444543 | PubTator, text mining | PubMed |
| Recent Advances in Transcription Factors Biomarkers and Targeted Therapies Focusing on Epithelial-Mesenchymal Transition. | Cancers (Basel) | 2023 | 37444447 | PubTator, text mining | PubMed |
| Role of N6-methyladenosine RNA modification in gastric cancer. | Cell Death Discov | 2023 | 37443100 | PubTator, text mining | PubMed |
| REST, RCOR1 and RCOR2 expression is reduced in osteoarthritic chondrocytes and contributes to increasing MMP13 and ADAMTS5 expression through upregulating HES1. | Cell Signal | 2023 | 37442513 | PubTator, text mining | PubMed |
| Diagnostic potential and pathogenic performance of circulating miR-146b, miR-194, and miR-214 in liver fibrosis. | Noncoding RNA Res | 2023 | 37434946 | PubTator, text mining | PubMed |
| The emerging roles of long noncoding RNAs in lymphatic vascular development and disease. | Cell Mol Life Sci | 2023 | 37407839 | PubTator, text mining | PubMed |
| Long noncoding RNA (lncRNA) H19: An essential developmental regulator with expanding roles in cancer, stem cell differentiation, and metabolic diseases. | Genes Dis | 2023 | 37397543 | PubTator, text mining | PubMed |
| Evolutionary Shortcuts via Multinucleotide Substitutions and Their Impact on Natural Selection Analyses. | Mol Biol Evol | 2023 | 37395787 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23186/papers?page=9